Eye Flu (Conjunctivitis) Market Growth Accelerated by Rising Prevalence of Eye Ailments

 Eye flu, also known as conjunctivitis, is a highly contagious infectious disease that causes inflammation or infection of the transparent membrane (conjunctiva) that lines the eyelids and covers the white part of the eye. It is characterized by discomfort, discharge, and swelling or redness of eyes. Conjunctivitis is easy to diagnose due to burning sensation and watery eyes associated with it.

 The global Eye Flu (Conjunctivitis) Market is driven by rising prevalence of eye ailments owing to changing lifestyle and lack of personal hygiene. The global eye flu (conjunctivitis) Market is estimated to be valued at US$ 4.54 billion in 2023 and is expected to exhibit a CAGR of 8.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The rising prevalence of eye ailments has been a major driving factor for the growth of eye flu market. Long working hours on electronic devices and lack of proper hygiene are the major causes for increasing eye problems among people. Changing lifestyle with less physical activities and intake of junk food has further added to rising prevalence of eye diseases across the world. According to a recent report published by WHO, eye ailments affect nearly 2.2 billion people globally and account for significant economic burden of health systems worldwide. This has accelerated the growth of eye flu market over the recent years. Improved awareness regarding eye health and availability of effective treatment options are also augmenting the market growth.
Segment Analysis
The global eye flu (conjunctivitis) market is segmented on the basis of type, treatment, end user and geography. By type, the market is divided into bacterial conjunctivitis, viral conjunctivitis and allergic conjunctivitis. Among these, allergic conjunctivitis dominates the market as it accounts for over 50% of the cases and has a high rate of recurrence. By treatment, the market is classified into antibiotics, antivirals, anti-allergic and others. Antibiotics capture the major share as it is the most common treatment for bacterial conjunctivitis. By end user, the market is categorized into hospitals, eye clinics and others. Hospitals hold the largest share due to high preference of consumers to consult ophthalmologists for eye related ailments.

Key Takeaways
The global eye flu (conjunctivitis) market is expected to witness high growth.

Regional analysis: North America is projected to dominate the market during the forecast period. Increasing incidence of eye diseases, rising number of eye care clinics and hospitals and growing awareness about eye care are major factors driving the market in the region.

Key players operating in the eye flu (conjunctivitis) market are Novartis AG, Allergan plc, Bausch Health, Merck & Co. Inc. and Pfizer Inc. Novartis AG dominates the global market with its wide range of treatment options for conjunctivitis.